November 15, 2005


A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
+1 (978) 421-9655


Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637


ZOLL Displays Advanced Resuscitation Products at Medica 2005--Unveils E Series Defibrillator

Tuesday, November 15, 2005 – CHELMSFORD, MASS.—ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of resuscitation devices and software solutions, will display its innovative resuscitation technology at its stand (Hall 11/E55) at MEDICA 2005. As one of the largest international medical equipment and healthcare exhibitions, with more than 136,000 attendees, MEDICA 2005 will take place 16 November through 19 November at the Düsseldorf Trade Fair Centre in Germany.

ZOLL Unveils the E Series Defibrillator—First Public Display in Europe
ZOLL will unveil the E Series™, ZOLL’s newest defibrillator designed to meet the specific demands and extreme conditions of the pre-hospital environment as well as the demands of the hospital-transport environment. The E Series is the only defibrillator available today that:

• Features a suitcase-style design with an innovative, protective roll cage, allowing emergency personnel to carry or store the device more easily;

• Provides an EasyRead Tri-Mode Display™ screen for use in pitch dark or direct sunlight, providing superior readability and complete views of critical patient information from virtually any angle; and

• Is equipped with a built-in GPS clock, allowing customers to automatically synchronize all of their dispatch, defibrillator, and intervention call times, which helps improve overall data accuracy.

In addition to the E Series, ZOLL will also display other resuscitation products.

ZOLL AutoPulse Non-invasive Cardiac Support Pump

The AutoPulse® Non-invasive Cardiac Support Pump is revolutionary in its design and potential to offer better outcomes. Comprised of a backboard and a load-distributing LifeBand® that fastens across the patient’s chest, the AutoPulse can do chest compressions that humans are unable to do, while moving much more blood, more effectively (1-5) to the heart and brain. Today more than 150 hospitals and emergency medical agencies worldwide use the AutoPulse as part of their resuscitation protocols.

ZOLL AED Plus Automated External Defibrillator

The AED Plus™ automated external defibrillator (AED) offers Real CPR Help™, which helps rescuers see and hear how well they are performing the rate and depth of chest compressions during CPR. This real-time feedback mechanism helps rescuers with all collapsed victims, including those who only benefit from CPR. ZOLL was the first to offer this functionality in an AED in 2002.

About half of all collapsed victims require defibrillation. For other victims, however, who may have non-shockable heart rhythms, the critical action for survival is effective CPR. While roughly half of unresponsive victims need defibrillation, every one of them requires temporary circulatory support with CPR.


The AED Pro® offers capabilities for Basic Life Support (BLS) and Advanced Life Support (ALS) users, including ECG monitoring with standard ECG electrodes; AED capability with manual override, with controlled access for ALS users; and unmatched ruggedness and durability. The AED Pro is the only AED in the industry to pass a 1.5-meter drop test. ZOLL offers a limited-lifetime guarantee for the plastic housing, should it break. The AED Pro also can provide Real CPR Help for rescuers.

ResQPOD Circulatory Enhancer for Cardiac Arrest

The ResQPOD® Circulatory Enhancer for cardiac arrest, manufactured by Advanced Circulatory Systems, Inc. and distributed by ZOLL in Europe, increases blood flow to the body’s vital organs by creating a vacuum within the victim’s chest during the decompression phase of CPR. Its approach enhances CPR efficiency by utilizing the interdependence of the body’s respiratory and circulatory systems. With it, up to two times as much blood is circulated to the heart and brain when compared to CPR without the ResQPOD. A combination of animal and human studies show statistically significant levels of improvement in survival from cardiac arrest and normal neurological function when the ResQPOD is used in conjunction with standard CPR.

ZOLL M Series Line of Defibrillators and Monitors with Pacing Capability

The M Series™ defibrillator, ZOLL’s best-selling device, has been selected as the standard in leading healthcare facilities around the world. The M Series defibrillator combines the clinical superiority of ZOLL’s Rectilinear Biphasic™ waveform with portability, ease-of-use, and a vivid screen display. M Series and all ZOLL defibrillators use ZOLL’s patented pacing technology, which has been clinically shown to offer superior capture rates, provide lower mean capture thresholds, and allow better patient tolerance to external pacing. ZOLL will also display its airworthy M Series CCT, designed specifically for critical care transport needs.

Power Infuser

The Power Infuser®, manufactured and marketed by ZOLL’s Infusion Dynamics division, is the first small, lightweight, easy-to-use device that provides highly controlled, rapid delivery of intravenous (IV) fluids to trauma victims. Previously sold to the military, this product has applications in aeromedical transport, pre-hospital, and emergency room settings.

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries. The company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East, Asia, and Australia.

Certain statements contained in this press release regarding matters that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL’s ability to compete in the resuscitation business; acceptance of its various products; changes in regulations affecting the healthcare industry; general economic conditions; and those other factors discussed in the section entitled “Risk Factors” in ZOLL’s Quarterly Report on Form 10-Q, which was filed with the SEC on August 12, 2005.

# # #

© 2005 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. AED Plus, E Series, EasyRead Tri-Mode Display, M Series, Real CPR Help, and Rectilinear Biphasic are trademarks of ZOLL Medical Corporation. AED Pro, AutoPulse, LifeBand, Power Infuser, and ZOLL are registered trademarks of ZOLL Medical Corporation. ResQPOD is a registered trademark of Advanced Circulatory Systems, Inc. All trademarks are property of their respective owners.


1. Casner M et al. The impact of a new CPR assist device on rate of return of spontaneous circulation in out-of-hospital cardiac arrest. Prehospital Emergency Care. 2005;9:61-67.

2. Timerman S et al. Improved hemodynamic performance with a novel chest compression device during treatment of in-hospital cardiac arrest. Resuscitation. 2004;61:273-280.

3. Halperin HR et al. Improved hemodynamics with a novel chest compression device during a porcine model of cardiac arrest. Circulation. 2002:106(19)(Suppl II):538.

4. Ikeno F et al. Improved survival with a novel chest compression device during a porcine model of cardiac arrest. Circulation. 2003;108(17)(suppl IV):381.

5. Ornato JP et al. Improvement in field return of spontaneous circulation using circumferential chest compression cardiopulmonary resuscitation. Prehospital Emergency Care. 9(1):104.